YAP1 and hepatocellular carcinoma: The injection of verteporfin in YAP transgenic mice resulted in a reduction in liver size, whereas in wild‐type mice, it had no effect on liver tissue, suggesting its potential application as a therapeutic target in patients diagnosed with HCC.209